sars-cov-2

Documents about sars-cov-2

• Safety and Immunogenicity Trial of MPV/S-2P SARS-CoV-2 Vaccine in Adults#154719ClinicalTrials.gov
• Exploratory Study to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers#256963ClinicalTrials.gov
• Long-term immune response to mRNA anti-SARS-CoV-2 vaccination in patients with cancer.#258188NCBI PubMed Central
• Andrea Crisanti parla del fallimento del metodo GreenPass#274567Internet Archive OAI Repository
• High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination#288108HAL (France)
• Association of TNFRSF13B Gene Polymorphisms With SARS‐CoV‐2 Infection, Severity, and Humoral Immune Response in a Moroccan Population#288290HAL (France)
• Safety and Immunogenicity of Omicron Variant-Matched Vaccine Booster in Adults#307320ClinicalTrials.gov
• Intra-host diversity of SARS-CoV-2 in children with long-term and short-term excretion in nasopharyngeal samples#308391HAL (France)
• Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster#325156ClinicalTrials.gov
• Widespread gene-environment interactions shape the immune response to SARS-CoV-2 infection in hospitalized COVID-19 patients.#340445NCBI PubMed Central
• Unraveling the Mechanism of Drug Binding to SARS-CoV-2 RNA Pseudoknot With Thermodynamics-Driven Machine Learning.#360894NCBI PubMed Central
• Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and Adolescents#387223ClinicalTrials.gov
• Molecular mechanism by which SARS-CoV-2 Orf9b suppresses the Tom70-Hsp90 interaction to evade innate immunity.#420948NCBI PubMed Central
• Transmission Networks and Intervention Effects From SARS-CoV-2 Genomic and Social Network Data in Denmark#424592Europe PMC
• Paediatric COVID-19 severity across SARS-CoV-2 variants in hospitalised children in South Africa: a retrospective cohort study#435638bioRxiv / medRxiv
• Perfect as the Enemy of the Good: Using Low-Sensitivity Tests to Mitigate SARS-CoV-2 Outbreaks#468156Harvard DASH
• Mapping the Surveillance Data Infrastructure in the U.S. for SARS-CoV-2, Influenza, and Respiratory Syncytial Virus.#479303NCBI PubMed Central
• SARS-CoV-2 ORF9b exploits mitochondrial recruitment to TOMM70 for proteasomal protection and tunes inflammatory remodeling during lung infection#670027HAL (France)
• Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients#800290ClinicalTrials.gov
• Intubation Prediction in COVID-19 Patients Treated With Awake Prone Positioning#804715ClinicalTrials.gov
• SARS-CoV-2 Specific Immune Response After COVID-19 Vaccination in Cancer Patients#805105ClinicalTrials.gov
• Discovery of Tetrahydroisoquinoline-Based SARS-CoV-2 Helicase Inhibitors with Iterative, Deep Learning-Enhanced Virtual Screening.#823584NCBI PubMed Central
• Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults#845300ClinicalTrials.gov
• Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine#849353ClinicalTrials.gov
• Study of the Spread of COVID-19 in Saint Petersburg, Russia#856296ClinicalTrials.gov
• OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients#856473ClinicalTrials.gov
• Immune Profiling of COVID19-patients Admitted to ICU#859599ClinicalTrials.gov
• Covid-19 Epidemic on Acute Stroke Management#865482ClinicalTrials.gov
• Booster Dose Study to Assess the Safety and Immunogenicity of ACM-001 Administered Intramuscularly or Intranasally.#881405ClinicalTrials.gov
• Serological Surveillance for COVID-19 in Central North Carolina#881430ClinicalTrials.gov
• IRAK 4 Inhibitor (PF-06650833) in Hospitalized Patients With COVID-19 Pneumonia and Exuberant Inflammation.#876052ClinicalTrials.gov
• Evaluation of Safety and Immunogenicity of a SARS-CoV-2(Severe Acute Respiratory Syndrome Coronavirus 2) Booster Vaccine (LEM-mR203)#444758ClinicalTrials.gov
• Neurological and Neuropsychological Sequelae of COVID-19 Infection#837521ClinicalTrials.gov
• COVID-19 Related Health and Infection Control Practices Among Dentists#838879ClinicalTrials.gov
• An innovative technological infrastructure for managing SARS-CoV-2 data across different cohorts in compliance with General Data Protection Regulation#29925Semantic Scholar
• Disentangling the drivers of heterogeneity in SARS-CoV-2 transmission from data on viral load and daily contact rates#127867bioRxiv / medRxiv
• Study to Assess Safety, Reactogenicity and Immunogenicity of the VACCINE RNA MCTI CIMATEC HDT (HDT-301) Vaccine Against COVID-19#152494ClinicalTrials.gov
• Paired wastewater and clinical genomics across metropolitan and hospital catchments reveals SARS-CoV-2 relevant mutations#157811Unpaywall
• Helminth infection is linked to an impaired neutralisation response to SARS-CoV-2 post vaccination#164940Unpaywall
• Inequalities and determinants of unmet need for SARS-CoV-2 testing in Ghana, Burkina Faso and Madagascar (2020 - 2021).#193498NCBI PubMed Central
• Air conditioning, ventilation, and respiratory virus transmission potential in South India.#240454PubMed
• Effectiveness of the Fiocruz recombinant ChadOx1-nCoV19 against variants of SARS-CoV-2 in the Municipality of Botucatu-SP#242871Ora Oxford University Research
• Delayed humoral kinetics but stabilization of IgG responses in common variable immunodeficiency after SARS-CoV-2 mRNA booster vaccination#264624bioRxiv / medRxiv
• Safety and Immunogenicity of Prime-boost Vaccination of SARS-CoV-2 in Patients With Cancer#272431ClinicalTrials.gov
• Bacillus Calmette-Guérin Vaccination and SARS-CoV-2 Infection among Healthcare Workers: A Case-Control Study in Cape Verde.#275587NCBI PubMed Central
• Utilizing Constrained Bicyclic Peptides for In Vitro Diagnostics.#279401Apollo
• Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine#283088ClinicalTrials.gov
• Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) in Healthy Pregnant Women#300321ClinicalTrials.gov
• Association of SARS-CoV-2 infection with incident diabetes among U.S. Veterans in a prospective longitudinal cohort.#320683NCBI PubMed Central
• Disentangling infectiousness and susceptibility by age group using transmission pair data: a study of SARS-CoV-2 household transmission#339596bioRxiv / medRxiv